Global Nuclear Medicine Imaging Device Market Growth (Status and Outlook) 2024-2030

2024

Global Nuclear Medicine Imaging Device Market Growth (Status and Outlook) 2024-2030

Name: Global Nuclear Medicine Imaging Device Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001328
Price: 3450 USD
Availability: InStock
Rating: 5 (15.45 reviews)

The global Nuclear Medicine Imaging Device market, valued at US$ 11,160 million in 2024, is expected to expand with the rising demand for advanced medical diagnostic tools.

Bonafide Trust
24-09-2024
Pages : 86
Figures : 79
Tables : 95
Region : Global
Category : Lifescience & Healthcare
Pharmaceutical

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global nuclear medicine imaging device market is experiencing notable growth, fueled by the increasing demand for advanced imaging techniques and the rising prevalence of chronic diseases that require precise diagnosis and treatment. Nuclear medicine imaging devices utilize radiopharmaceuticals, which are radioactive compounds injected into the body to create images of organs and tissues. These devices play an essential role in diagnosing various health conditions, particularly in oncology, cardiology, and neurology. The key types of nuclear medicine imaging devices include positron emission tomography (PET) scanners, single-photon emission computed tomography (SPECT) scanners, and hybrid imaging systems, which combine nuclear medicine with other imaging modalities such as computed tomography (CT) or magnetic resonance imaging (MRI). These devices provide detailed and high-resolution images of the internal structures of the body, enabling doctors to detect diseases early, monitor treatment progress, and assess therapeutic responses. The global demand for nuclear medicine imaging devices is being driven by factors such as the aging population, the increasing prevalence of chronic conditions like cancer, cardiovascular diseases, and neurological disorders, and the growing preference for non-invasive diagnostic techniques. Additionally, advances in imaging technology, such as the integration of artificial intelligence (AI) and machine learning algorithms, have enhanced the diagnostic accuracy of nuclear medicine imaging devices. These advancements are improving image quality, reducing scan times, and enabling the interpretation of complex images with higher precision. Furthermore, the shift towards personalized medicine, where treatments are tailored to individual patients based on their unique disease characteristics, is also contributing to the market's growth, as nuclear imaging allows for better disease detection and treatment planning. Increased investments in research and development (R&D), along with improved healthcare infrastructure across both developed and emerging markets, are further accelerating the adoption of nuclear medicine imaging devices globally.

According to Publisher, the global Nuclear Medicine Imaging Device market size was valued at US$ 11160 million in 2024. With growing demand in downstream market, the Nuclear Medicine Imaging Device is forecast to a readjusted size of US$ 17040 million by 2030 with a CAGR of 6.2% during review period. The North American region holds the largest share of the global nuclear medicine imaging device market, driven by its advanced healthcare infrastructure, high healthcare spending, and early adoption of innovative medical technologies. The United States, in particular, is a key contributor to the growth of this market, with its large number of healthcare facilities and a strong presence of manufacturers of nuclear medicine imaging devices and radiopharmaceuticals. The increasing incidence of cancer, cardiovascular diseases, and neurological disorders in the United States has significantly contributed to the demand for nuclear imaging technologies. Additionally, the country's well-established reimbursement policies, along with government initiatives supporting the adoption of advanced medical technologies, have provided a favorable environment for the market's expansion. In Europe, countries such as Germany, the United Kingdom, and France are major players in the nuclear medicine imaging device market. The European market is experiencing growth due to the rising demand for diagnostic imaging in the treatment of cancer, heart diseases, and neurological disorders, as well as an increasing emphasis on preventive healthcare. The introduction of hybrid imaging systems, which combine PET and CT or MRI, has further expanded the market in this region by offering enhanced diagnostic accuracy and improved patient outcomes. The Asia-Pacific region is expected to witness the highest growth rate in the global market, driven by the increasing healthcare investments, growing awareness about nuclear medicine imaging, and improving healthcare infrastructure in countries such as China, India, Japan, and South Korea. The rising prevalence of chronic diseases in these countries, along with the growing adoption of advanced imaging technologies, presents significant opportunities for market growth. The Latin American and Middle Eastern markets are also showing positive growth trends, although at a slower pace compared to other regions, due to increasing healthcare awareness and improvements in healthcare facilities.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The global nuclear medicine imaging device market can be segmented by device type, which includes PET scanners, SPECT scanners, and hybrid imaging systems. PET scanners are one of the most widely used devices in nuclear medicine imaging due to their ability to provide three-dimensional images of metabolic activity in the body. These scanners are highly effective in detecting cancer, cardiovascular diseases, and neurological conditions, offering early detection and more accurate diagnosis. The demand for PET imaging devices is particularly strong in oncology, where they are used to detect and assess tumors at the molecular level. In cardiology, PET scanners are used to evaluate myocardial perfusion and detect coronary artery disease. SPECT scanners, which provide detailed two-dimensional images, are also widely used in clinical settings for imaging the heart, brain, and bones. SPECT imaging is valuable in diagnosing conditions such as ischemic heart disease, brain disorders, and bone infections. The SPECT market continues to grow due to its cost-effectiveness and widespread availability in medical facilities. Hybrid imaging systems, which combine PET or SPECT with CT or MRI technologies, are increasingly gaining popularity due to their ability to provide both anatomical and functional imaging in a single scan. These systems offer superior diagnostic accuracy, allowing physicians to obtain detailed images of the body’s internal structures while simultaneously evaluating the functional processes of organs and tissues. Hybrid systems are particularly beneficial in oncology, as they help in assessing tumor size, location, and metastasis. The combination of PET with CT (PET/CT) and PET with MRI (PET/MRI) has been instrumental in advancing precision medicine, providing doctors with comprehensive information for accurate diagnosis and treatment planning. As technological advancements continue, the nuclear medicine imaging device market is likely to witness innovations in hybrid imaging systems, with improved image quality and faster scan times, further driving market growth.

The application-based segmentation of the nuclear medicine imaging device market includes oncology, cardiology, neurology, and other therapeutic applications. Oncology is the largest and fastest-growing application segment, as nuclear medicine imaging plays a crucial role in cancer diagnosis, staging, and treatment. Nuclear imaging devices, particularly PET and SPECT scanners, are used to detect tumors, assess tumor metabolism, and evaluate treatment responses. These devices allow for the early detection of cancers such as lung, breast, prostate, and colorectal cancers, enabling timely interventions and improved patient outcomes. The oncology segment is further driven by the rising incidence of cancer globally, especially among aging populations, which has significantly increased the demand for nuclear medicine imaging in early diagnosis and monitoring. In cardiology, nuclear medicine imaging devices are extensively used to evaluate heart conditions, including coronary artery disease, heart failure, and myocardial infarction. Myocardial perfusion imaging (MPI) with SPECT and PET scanners is commonly used to assess blood flow to the heart, detect blockages, and evaluate the function of the heart muscle. Nuclear imaging in cardiology is essential for non-invasive diagnosis and is increasingly preferred due to its accuracy and ability to assess heart conditions in real-time. Neurology is another significant application area for nuclear medicine imaging, particularly in the diagnosis and management of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and epilepsy. PET and SPECT imaging technologies allow for the evaluation of brain function, the detection of abnormal brain activity, and the identification of disease-related changes in the brain’s structure. These technologies are valuable in the early diagnosis of neurological conditions, helping to differentiate between various disorders and monitor disease progression. Other applications of nuclear medicine imaging include endocrinology, hematology, and infection imaging, where nuclear imaging is used to diagnose thyroid disorders, blood cancers, and infections. As the focus on personalized medicine and early disease detection continues to grow, the demand for nuclear medicine imaging devices in these and other therapeutic areas is expected to expand, driving overall market growth.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nuclear Medicine Imaging Device Market Size 2019-2030
2.1.2 Nuclear Medicine Imaging Device Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nuclear Medicine Imaging Device Segment by Type
2.2.1 PET
2.2.2 SPECT
2.3 Nuclear Medicine Imaging Device Market Size by Type
2.3.1 Nuclear Medicine Imaging Device Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nuclear Medicine Imaging Device Market Size Market Share by Type (2019-2024)
2.4 Nuclear Medicine Imaging Device Segment by Application
2.4.1 Hospital
2.4.2 Third-party Imaging Center
2.4.3 Other
2.5 Nuclear Medicine Imaging Device Market Size by Application
2.5.1 Nuclear Medicine Imaging Device Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Nuclear Medicine Imaging Device Market Size Market Share by Application (2019-2024)
3 Nuclear Medicine Imaging Device Market Size by Player
3.1 Nuclear Medicine Imaging Device Market Size Market Share by Players
3.1.1 Global Nuclear Medicine Imaging Device Revenue by Players (2019-2024)
3.1.2 Global Nuclear Medicine Imaging Device Revenue Market Share by Players (2019-2024)
3.2 Global Nuclear Medicine Imaging Device Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nuclear Medicine Imaging Device by Regions
4.1 Nuclear Medicine Imaging Device Market Size by Regions (2019-2024)
4.2 Americas Nuclear Medicine Imaging Device Market Size Growth (2019-2024)
4.3 APAC Nuclear Medicine Imaging Device Market Size Growth (2019-2024)
4.4 Europe Nuclear Medicine Imaging Device Market Size Growth (2019-2024)
4.5 Middle East & Africa Nuclear Medicine Imaging Device Market Size Growth (2019-2024)
5 Americas
5.1 Americas Nuclear Medicine Imaging Device Market Size by Country (2019-2024)
5.2 Americas Nuclear Medicine Imaging Device Market Size by Type (2019-2024)
5.3 Americas Nuclear Medicine Imaging Device Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Medicine Imaging Device Market Size by Region (2019-2024)
6.2 APAC Nuclear Medicine Imaging Device Market Size by Type (2019-2024)
6.3 APAC Nuclear Medicine Imaging Device Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nuclear Medicine Imaging Device by Country (2019-2024)
7.2 Europe Nuclear Medicine Imaging Device Market Size by Type (2019-2024)
7.3 Europe Nuclear Medicine Imaging Device Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nuclear Medicine Imaging Device by Region (2019-2024)
8.2 Middle East & Africa Nuclear Medicine Imaging Device Market Size by Type (2019-2024)
8.3 Middle East & Africa Nuclear Medicine Imaging Device Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nuclear Medicine Imaging Device Market Forecast
10.1 Global Nuclear Medicine Imaging Device Forecast by Regions (2025-2030)
10.1.1 Global Nuclear Medicine Imaging Device Forecast by Regions (2025-2030)
10.1.2 Americas Nuclear Medicine Imaging Device Forecast
10.1.3 APAC Nuclear Medicine Imaging Device Forecast
10.1.4 Europe Nuclear Medicine Imaging Device Forecast
10.1.5 Middle East & Africa Nuclear Medicine Imaging Device Forecast
10.2 Americas Nuclear Medicine Imaging Device Forecast by Country (2025-2030)
10.2.1 United States Nuclear Medicine Imaging Device Market Forecast
10.2.2 Canada Nuclear Medicine Imaging Device Market Forecast
10.2.3 Mexico Nuclear Medicine Imaging Device Market Forecast
10.2.4 Brazil Nuclear Medicine Imaging Device Market Forecast
10.3 APAC Nuclear Medicine Imaging Device Forecast by Region (2025-2030)
10.3.1 China Nuclear Medicine Imaging Device Market Forecast
10.3.2 Japan Nuclear Medicine Imaging Device Market Forecast
10.3.3 Korea Nuclear Medicine Imaging Device Market Forecast
10.3.4 Southeast Asia Nuclear Medicine Imaging Device Market Forecast
10.3.5 India Nuclear Medicine Imaging Device Market Forecast
10.3.6 Australia Nuclear Medicine Imaging Device Market Forecast
10.4 Europe Nuclear Medicine Imaging Device Forecast by Country (2025-2030)
10.4.1 Germany Nuclear Medicine Imaging Device Market Forecast
10.4.2 France Nuclear Medicine Imaging Device Market Forecast
10.4.3 UK Nuclear Medicine Imaging Device Market Forecast
10.4.4 Italy Nuclear Medicine Imaging Device Market Forecast
10.4.5 Russia Nuclear Medicine Imaging Device Market Forecast
10.5 Middle East & Africa Nuclear Medicine Imaging Device Forecast by Region (2025-2030)
10.5.1 Egypt Nuclear Medicine Imaging Device Market Forecast
10.5.2 South Africa Nuclear Medicine Imaging Device Market Forecast
10.5.3 Israel Nuclear Medicine Imaging Device Market Forecast
10.5.4 Turkey Nuclear Medicine Imaging Device Market Forecast
10.5.5 GCC Countries Nuclear Medicine Imaging Device Market Forecast
10.6 Global Nuclear Medicine Imaging Device Forecast by Type (2025-2030)
10.7 Global Nuclear Medicine Imaging Device Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Siemens
11.1.1 Siemens Company Information
11.1.2 Siemens Nuclear Medicine Imaging Device Product Offered
11.1.3 Siemens Nuclear Medicine Imaging Device Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Siemens Main Business Overview
11.1.5 Siemens Latest Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Information
11.2.2 GE Healthcare Nuclear Medicine Imaging Device Product Offered
11.2.3 GE Healthcare Nuclear Medicine Imaging Device Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 GE Healthcare Main Business Overview
11.2.5 GE Healthcare Latest Developments
11.3 Philips
11.3.1 Philips Company Information
11.3.2 Philips Nuclear Medicine Imaging Device Product Offered
11.3.3 Philips Nuclear Medicine Imaging Device Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Philips Main Business Overview
11.3.5 Philips Latest Developments
11.4 Canon Medical
11.4.1 Canon Medical Company Information
11.4.2 Canon Medical Nuclear Medicine Imaging Device Product Offered
11.4.3 Canon Medical Nuclear Medicine Imaging Device Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Canon Medical Main Business Overview
11.4.5 Canon Medical Latest Developments
11.5 Hitachi Medical
11.5.1 Hitachi Medical Company Information
11.5.2 Hitachi Medical Nuclear Medicine Imaging Device Product Offered
11.5.3 Hitachi Medical Nuclear Medicine Imaging Device Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Hitachi Medical Main Business Overview
11.5.5 Hitachi Medical Latest Developments
11.6 Mediso
11.6.1 Mediso Company Information
11.6.2 Mediso Nuclear Medicine Imaging Device Product Offered
11.6.3 Mediso Nuclear Medicine Imaging Device Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Mediso Main Business Overview
11.6.5 Mediso Latest Developments
11.7 United Imaging
11.7.1 United Imaging Company Information
11.7.2 United Imaging Nuclear Medicine Imaging Device Product Offered
11.7.3 United Imaging Nuclear Medicine Imaging Device Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 United Imaging Main Business Overview
11.7.5 United Imaging Latest Developments
11.8 Neusoft Medical
11.8.1 Neusoft Medical Company Information
11.8.2 Neusoft Medical Nuclear Medicine Imaging Device Product Offered
11.8.3 Neusoft Medical Nuclear Medicine Imaging Device Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Neusoft Medical Main Business Overview
11.8.5 Neusoft Medical Latest Developments
11.9 Topgrade HealthCare
11.9.1 Topgrade HealthCare Company Information
11.9.2 Topgrade HealthCare Nuclear Medicine Imaging Device Product Offered
11.9.3 Topgrade HealthCare Nuclear Medicine Imaging Device Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Topgrade HealthCare Main Business Overview
11.9.5 Topgrade HealthCare Latest Developments
12 Research Findings and Conclusion

Table 1. Nuclear Medicine Imaging Device Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of PET
Table 3. Major Players of SPECT
Table 4. Nuclear Medicine Imaging Device Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Nuclear Medicine Imaging Device Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Nuclear Medicine Imaging Device Market Size Market Share by Type (2019-2024)
Table 7. Nuclear Medicine Imaging Device Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Nuclear Medicine Imaging Device Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Nuclear Medicine Imaging Device Market Size Market Share by Application (2019-2024)
Table 10. Global Nuclear Medicine Imaging Device Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Nuclear Medicine Imaging Device Revenue Market Share by Player (2019-2024)
Table 12. Nuclear Medicine Imaging Device Key Players Head office and Products Offered
Table 13. Nuclear Medicine Imaging Device Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Nuclear Medicine Imaging Device Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Nuclear Medicine Imaging Device Market Size Market Share by Regions (2019-2024)
Table 18. Global Nuclear Medicine Imaging Device Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Nuclear Medicine Imaging Device Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Nuclear Medicine Imaging Device Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Nuclear Medicine Imaging Device Market Size Market Share by Country (2019-2024)
Table 22. Americas Nuclear Medicine Imaging Device Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Nuclear Medicine Imaging Device Market Size Market Share by Type (2019-2024)
Table 24. Americas Nuclear Medicine Imaging Device Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Nuclear Medicine Imaging Device Market Size Market Share by Application (2019-2024)
Table 26. APAC Nuclear Medicine Imaging Device Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Nuclear Medicine Imaging Device Market Size Market Share by Region (2019-2024)
Table 28. APAC Nuclear Medicine Imaging Device Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Nuclear Medicine Imaging Device Market Size Market Share by Type (2019-2024)
Table 30. APAC Nuclear Medicine Imaging Device Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Nuclear Medicine Imaging Device Market Size Market Share by Application (2019-2024)
Table 32. Europe Nuclear Medicine Imaging Device Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Nuclear Medicine Imaging Device Market Size Market Share by Country (2019-2024)
Table 34. Europe Nuclear Medicine Imaging Device Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Nuclear Medicine Imaging Device Market Size Market Share by Type (2019-2024)
Table 36. Europe Nuclear Medicine Imaging Device Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Nuclear Medicine Imaging Device Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Nuclear Medicine Imaging Device Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Nuclear Medicine Imaging Device Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Nuclear Medicine Imaging Device Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Nuclear Medicine Imaging Device Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Nuclear Medicine Imaging Device Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Nuclear Medicine Imaging Device Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Nuclear Medicine Imaging Device
Table 45. Key Market Challenges & Risks of Nuclear Medicine Imaging Device
Table 46. Key Industry Trends of Nuclear Medicine Imaging Device
Table 47. Global Nuclear Medicine Imaging Device Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Nuclear Medicine Imaging Device Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Nuclear Medicine Imaging Device Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Nuclear Medicine Imaging Device Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Siemens Details, Company Type, Nuclear Medicine Imaging Device Area Served and Its Competitors
Table 52. Siemens Nuclear Medicine Imaging Device Product Offered
Table 53. Siemens Nuclear Medicine Imaging Device Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Siemens Main Business
Table 55. Siemens Latest Developments
Table 56. GE Healthcare Details, Company Type, Nuclear Medicine Imaging Device Area Served and Its Competitors
Table 57. GE Healthcare Nuclear Medicine Imaging Device Product Offered
Table 58. GE Healthcare Main Business
Table 59. GE Healthcare Nuclear Medicine Imaging Device Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. GE Healthcare Latest Developments
Table 61. Philips Details, Company Type, Nuclear Medicine Imaging Device Area Served and Its Competitors
Table 62. Philips Nuclear Medicine Imaging Device Product Offered
Table 63. Philips Main Business
Table 64. Philips Nuclear Medicine Imaging Device Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Philips Latest Developments
Table 66. Canon Medical Details, Company Type, Nuclear Medicine Imaging Device Area Served and Its Competitors
Table 67. Canon Medical Nuclear Medicine Imaging Device Product Offered
Table 68. Canon Medical Main Business
Table 69. Canon Medical Nuclear Medicine Imaging Device Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Canon Medical Latest Developments
Table 71. Hitachi Medical Details, Company Type, Nuclear Medicine Imaging Device Area Served and Its Competitors
Table 72. Hitachi Medical Nuclear Medicine Imaging Device Product Offered
Table 73. Hitachi Medical Main Business
Table 74. Hitachi Medical Nuclear Medicine Imaging Device Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Hitachi Medical Latest Developments
Table 76. Mediso Details, Company Type, Nuclear Medicine Imaging Device Area Served and Its Competitors
Table 77. Mediso Nuclear Medicine Imaging Device Product Offered
Table 78. Mediso Main Business
Table 79. Mediso Nuclear Medicine Imaging Device Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Mediso Latest Developments
Table 81. United Imaging Details, Company Type, Nuclear Medicine Imaging Device Area Served and Its Competitors
Table 82. United Imaging Nuclear Medicine Imaging Device Product Offered
Table 83. United Imaging Main Business
Table 84. United Imaging Nuclear Medicine Imaging Device Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. United Imaging Latest Developments
Table 86. Neusoft Medical Details, Company Type, Nuclear Medicine Imaging Device Area Served and Its Competitors
Table 87. Neusoft Medical Nuclear Medicine Imaging Device Product Offered
Table 88. Neusoft Medical Main Business
Table 89. Neusoft Medical Nuclear Medicine Imaging Device Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Neusoft Medical Latest Developments
Table 91. Topgrade HealthCare Details, Company Type, Nuclear Medicine Imaging Device Area Served and Its Competitors
Table 92. Topgrade HealthCare Nuclear Medicine Imaging Device Product Offered
Table 93. Topgrade HealthCare Main Business
Table 94. Topgrade HealthCare Nuclear Medicine Imaging Device Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Topgrade HealthCare Latest Developments
List of

Figure 1. Nuclear Medicine Imaging Device Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nuclear Medicine Imaging Device Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Nuclear Medicine Imaging Device Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Nuclear Medicine Imaging Device Sales Market Share by Country/Region (2023)
Figure 8. Nuclear Medicine Imaging Device Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Nuclear Medicine Imaging Device Market Size Market Share by Type in 2023
Figure 10. Nuclear Medicine Imaging Device in Hospital
Figure 11. Global Nuclear Medicine Imaging Device Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Nuclear Medicine Imaging Device in Third-party Imaging Center
Figure 13. Global Nuclear Medicine Imaging Device Market: Third-party Imaging Center (2019-2024) & ($ Millions)
Figure 14. Nuclear Medicine Imaging Device in Other
Figure 15. Global Nuclear Medicine Imaging Device Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Nuclear Medicine Imaging Device Market Size Market Share by Application in 2023
Figure 17. Global Nuclear Medicine Imaging Device Revenue Market Share by Player in 2023
Figure 18. Global Nuclear Medicine Imaging Device Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Nuclear Medicine Imaging Device Market Size 2019-2024 ($ Millions)
Figure 20. APAC Nuclear Medicine Imaging Device Market Size 2019-2024 ($ Millions)
Figure 21. Europe Nuclear Medicine Imaging Device Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Nuclear Medicine Imaging Device Market Size 2019-2024 ($ Millions)
Figure 23. Americas Nuclear Medicine Imaging Device Value Market Share by Country in 2023
Figure 24. United States Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Nuclear Medicine Imaging Device Market Size Market Share by Region in 2023
Figure 29. APAC Nuclear Medicine Imaging Device Market Size Market Share by Type in 2023
Figure 30. APAC Nuclear Medicine Imaging Device Market Size Market Share by Application in 2023
Figure 31. China Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Nuclear Medicine Imaging Device Market Size Market Share by Country in 2023
Figure 38. Europe Nuclear Medicine Imaging Device Market Size Market Share by Type (2019-2024)
Figure 39. Europe Nuclear Medicine Imaging Device Market Size Market Share by Application (2019-2024)
Figure 40. Germany Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Nuclear Medicine Imaging Device Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Nuclear Medicine Imaging Device Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Nuclear Medicine Imaging Device Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Nuclear Medicine Imaging Device Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 54. APAC Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 55. Europe Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 57. United States Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 58. Canada Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 61. China Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 62. Japan Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 63. Korea Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 65. India Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 66. Australia Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 67. Germany Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 68. France Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 69. UK Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 70. Italy Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 71. Russia Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 72. Spain Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 75. Israel Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Nuclear Medicine Imaging Device Market Size 2025-2030 ($ Millions)
Figure 78. Global Nuclear Medicine Imaging Device Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Nuclear Medicine Imaging Device Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted